Engineering and Development

Legal and Compliance

Accounting and Finance

Management and Executive

Customer Service and Support

Chief Human Resources Officer

President

Revolution Medicines Insider Sold Shares Worth $614,558, According to a Recent SEC Filing

Revolution Medicines Insider Sold Shares Worth $5,557,754, According to a Recent SEC Filing

The week in pharma: action, reaction and insight – week to September 12

Revolution takes early stage cues for a phase III in pancreatic cancer

Associate Director, CMC Regulatory

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies. The Associate Director, CMC Regulatory will be responsible for developing and implementing regulatory strategies and coordinating submissions to support the clinical development and marketing approval of the company's pipeline products.

Sign up with Google

Sign in with Google